Cargando…
Calpains: Potential Targets for Alternative Chemotherapeutic Intervention Against Human Pathogenic Trypanosomatids
The treatment for both leishmaniasis and trypanosomiasis, which are severe human infections caused by trypanosomatids belonging to Leishmania and Trypanosoma genera, respectively, is extremely limited because of concerns of toxicity and efficacy with the available anti-protozoan drugs, as well as th...
Autores principales: | M.H, Branquinha, F.A, Marinho, L.S, Sangenito, S.S.C, Oliveira, K.C, Gonçalves, V, Ennes-Vidal, C.M, d’Avila-Levy, A.L.S, Santos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181241/ https://www.ncbi.nlm.nih.gov/pubmed/23899207 http://dx.doi.org/10.2174/0929867311320250010 |
Ejemplares similares
-
Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022) -
Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy
por: Santos, L.O., et al.
Publicado: (2013) -
The Diverse Calpain Family in Trypanosomatidae: Functional Proteins Devoid of Proteolytic Activity?
por: Ennes-Vidal, Vítor, et al.
Publicado: (2021) -
Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
por: Branquinha, Marta H., et al.
Publicado: (2022) -
MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
por: Ennes-Vidal, Vítor, et al.
Publicado: (2011)